Torrent Pharma initiates voluntary recall of Semalix injection pens

Torrent Pharmaceuticals Limited is implementing a voluntary recall of select batches of Semalix injection disposable pens (2 mg & 4 mg) as a precautionary measure. This action follows a product recall notification from their manufacturer, Dr. Reddy's Laboratories Ltd. (DRL), for technical evaluation. Torrent emphasizes that patient safety is paramount and there is no risk to patients currently on this treatment. Other Semaglutide products sold by Torrent, including oral formulations and different injection strengths/types manufactured by other entities, remain unaffected. Patients seeking clarification can contact pv@torrentpharma.com.